DENG Lanting, ZOU Yuyan, WANG Yan, DENG Quancheng, TIAN Ronghua. Correlation between CT score and hs-CRP at different stages in COVID-19 patients[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2020, 41(3): 216-219. DOI: 10.3969/j.issn.2095-5227.2020.03.004
Citation: DENG Lanting, ZOU Yuyan, WANG Yan, DENG Quancheng, TIAN Ronghua. Correlation between CT score and hs-CRP at different stages in COVID-19 patients[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2020, 41(3): 216-219. DOI: 10.3969/j.issn.2095-5227.2020.03.004

Correlation between CT score and hs-CRP at different stages in COVID-19 patients

More Information
  • Corresponding author:

    TIAN Ronghua. Email: tianrh9999@163.com

  • Received Date: February 29, 2020
  • Available Online: July 06, 2021
  •   Objective  To explore the value of chest CT score and hs-CRP in the staging diagnosis of COVID-19.
      Methods  Clinical data about 65 cases with confirmed COVID-19 admitted to our hospital from January to February in 2020 were retrospectively analyzed. They were divided into four groups according to the disease progression: stage 1 (0-3 days), stage 2 (4-7 days), stage 3 (8-14 days) and stage 4 (15-21 days). According to the clinical classification, the patients were divided into two groups: mild/moderate group and severe/critically ill group. CT score was calculated according to the extent of chest CT lesions, and the correlation between CT score and hs-CRP was analyzed.
      Results  Of the 65 cases, there were 33 males and 32 females, with an average age of 52.77±13.95 years. According to the disease progression, the CT score (stage 3 vs stage 1, stage 2, and stage 4: 11.27±2.02 vs 2.79±1.25, 6.40±1.32, 2.50±1.42) and hs-CRP value (stage 3 vs stage 1, stage 2, and stage 4: [81.61±63.46] mg/L vs [8.94±6.16] mg/L, [41.78±19.79] mg/L, [7.10±7.74] mg/L) in stage 3 were significantly higher than those in the other three stages (all P < 0.05). According to clinical classification, the CT score (12.05±1.75 vs 4.11±2.25) and serum hs-CRP value ([82.17±64.97] mg/L vs [25.01±21.77] mg/L) were higher in severe/critically ill patients than in mild/moderate patients (P < 0.05). There was a positive correlation between CT score and hs-CRP value (r=0.76, P=0.001).
      Conclusion  CT score combined with hs-CRP plays an important role in the diagnosis and dynamic evaluation of COVID-19.
  • [1]
    [2]
    李泳枝, 何欢, 陈清. 新型冠状病毒肺炎研究进展[J/OL]. http://kns.cnki.net/kcms/detail/44.1503.R.20200305.1903.002.html.
    [3]
    邱添, 赵志刚, 杨震, 等. 血清降钙素原、C-反应蛋白和白细胞介素6联合检测对脓毒症预后评估的临床价值[J]. 解放军医学院学报, 2016, 37(6): 552-555. doi: 10.3969/j.issn.2095-5227.2016.06.007
    [4]
    国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
    [5]
    史河水, 韩小雨, 樊艳青, 等. 新型冠状病毒(2019-nCoV)感染的肺炎临床特征及影像学表现[J/OL]. https://kns.cnki.net/KCMS/detail/42.1187.R.20200206.1616.004.html.
    [6]
    徐富明, 黄龙, 张慧, 等. 行为贫困陷阱的心理机制与管理对策: 基于认知与动机双视角[J/OL]. http://www.chinaxiv.org/abs/202002.00072.
    [7]
    国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第五版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
    [8]
    占林兵, 谢波, 华锋, 等. 血清C反应蛋白、降钙素原及乳酸在重症肺炎中的变化及临床意义[J]. 中华全科医学, 2015, 13(3): 367-368, 404. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201503010.htm
    [9]
    刘金山. C反应蛋白、降钙素原、D-二聚体检测在社区获得性肺炎中的应用及临床意义[J]. 中国现代药物应用, 2019, 13(2): 36-38. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY201902021.htm
    [10]
    管汉雄, 熊颖, 申楠茜, 等. 新型冠状病毒肺炎(COVID-19)临床影像学特征[J]. 放射学实践, 2020, 35(2): 125-130. https://www.cnki.com.cn/Article/CJFDTOTAL-FSXS202002002.htm
    [11]
    刘发明, 丁惠玲, 龚晓明, 等. 新型冠状病毒肺炎(COVID-19)的胸部CT表现与临床特点[J/OL]. https://doi.org/10.13609/j.cnki.1000-0313.2020.03.001.
    [12]
    王锦程, 刘锦鹏, 王园园, 等. 2019冠状病毒病(COVID-19)患者胸部CT影像学动态变化[J/OL]. http://kns.cnki.net/kcms/detail/33.1248.R.20200225.1528.004.html.
    [13]
    姬广海, 黄满华, 张庆, 等. 新型冠状病毒肺炎CT表现及动态变化[J/OL]. https://doi.org/10.13929/j.issn.1003-3289.2020.03.016.
    [14]
    Green JP, Berger T, Garg N, et al. Serum lactate is a better predictor of short-term mortality when stratified by C-reactive protein in adult emergency department patients hospitalized for a suspected infection[J]. Ann Emerg Med, 2011, 57(3): 291-295. doi: 10.1016/j.annemergmed.2010.10.016
    [15]
    姚建华, 谢立德, 汪健蕾, 等. 动脉血乳酸和C-反应蛋白对重症肺炎预后的评估价值[J]. 临床肺科杂志, 2013, 18(4): 600-601. doi: 10.3969/j.issn.1009-6663.2013.04.010
    [16]
    Luo W, Yu H, Gou J, et al. Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia (COVID-19)[J/OL]. https://www.preprints.org/manuscript/202002.0407/v2.
    [17]
    国家卫生健康委员会. 新型冠状病毒感染的肺炎诊疗方案(试行第七版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
  • Cited by

    Periodical cited type(6)

    1. 伍啟华,陈立,蔡海荣,蔡鑫桂,刘淑玲,黄妙纯,陈伯钧,叶烨,李庆敏. 中西医结合治疗新型冠状病毒感染危重型气管插管患者的回顾性研究. 时珍国医国药. 2024(04): 921-924 .
    2. 纪丙军,赵昱东,邓金铭,赵田田,任鹏雷,宋芹. COVID-19恢复期患者胸部CT特征与肺功能相关性研究. 社区医学杂志. 2023(04): 191-196 .
    3. 刘安平,王伟,廖军委,汪雪琴,刘先军,曾莹莹,曹阳,周琴. 加味桑菊饮治疗风热犯肺证新型冠状病毒肺炎疗效观察. 现代中西医结合杂志. 2021(22): 2395-2399 .
    4. 张嘉玉,李萍,李志芳. 新型冠状病毒肺炎疫情期间社区女性居民心理影响因素分析及干预效果评价. 长治医学院学报. 2020(02): 81-86 .
    5. 廖建勇,杜静波,姚永刚,张斌,勾振恒,郭小会,苏晓华,曹婉钰,王秀英. 新型冠状病毒肺炎CT影像分型与临床诊治的相关性研究. 实用医技杂志. 2020(08): 981-984 .
    6. 孟宪泽,辛志俊,孙擎,林慧艳,于海涛,刘涛,楚立云,吕坤聚,李露嘉. 血清IgM、IgG抗体双阴性2019冠状病毒病患者临床特征分析. 解放军医学院学报. 2020(09): 860-864 . 本站查看

    Other cited types(1)

Catalog

    Article Metrics

    Article views (98) PDF downloads (13) Cited by(7)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return